SCPH

scPharmaceuticals (SCPH)

About scPharmaceuticals (SCPH)

scPharmaceuticals, Inc. engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include FUROSCIX, a furosemide injection which is used as parenteral diuretic in treating heart failure and scCeftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA.

Details

Daily high
$3.14
Daily low
$2.99
Price at open
$3.07
52 Week High
$5.70
52 Week Low
$2.75
Market cap
152.6M
Dividend yield
0.00%
Volume
163,681
Avg. volume
592,215
P/E ratio
-1.60

scPharmaceuticals News

Details

Daily high
$3.14
Daily low
$2.99
Price at open
$3.07
52 Week High
$5.70
52 Week Low
$2.75
Market cap
152.6M
Dividend yield
0.00%
Volume
163,681
Avg. volume
592,215
P/E ratio
-1.60